| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 38 |
| 1 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 29 |
| 2 | TACROLIMUS OINTMENT 0.1% | 29 |
| 3 | METHYLPREDNISOLONE | 25 |
| 4 | PREDNISONE | 25 |
| 5 | VALGANCICLOVIR | 20 |
| 6 | VALGANCICLOVIR HYDROCHLORIDE | 20 |
| 7 | EMPAGLIFLOZIN | 19 |
| 8 | ALEMTUZUMAB | 18 |
| 9 | AMPHOTERICIN B | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CASPOFUNGIN ACETATE | 4 | 0.0025 |
| 1 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 15 | 0.0018 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 12 | 0.0014 |
| 3 | AMPHOTERICIN B | 17 | 0.0013 |
| 4 | BELATACEPT | 6 | 0.0013 |
| 5 | VALGANCICLOVIR | 20 | 0.0010 |
| 6 | PIPERACILLIN AND TAZOBACTAM | 13 | 0.0010 |
| 7 | ALEMTUZUMAB | 18 | 0.0009 |
| 8 | ISONIAZID | 12 | 0.0007 |
| 9 | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | 13 | 0.0007 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 17 | 0.0013 |
| 1 | Selective T Cell Costimulation Blocker [EPC] | 6 | 0.0013 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 18 | 0.0009 |
| 3 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 19 | 0.0009 |
| 4 | Polyene Antifungal [EPC] | 29 | 0.0007 |
| 5 | Antimycobacterial [EPC] | 12 | 0.0005 |
| 6 | Sulfone [EPC] | 5 | 0.0005 |
| 7 | Penem Antibacterial [EPC] | 15 | 0.0004 |
| 8 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 5 | 0.0002 |